Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by United Advisor Group LLC

United Advisor Group LLC cut its holdings in Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 11.8% during the 3rd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 10,603 shares of the pharmacy operator’s stock after selling 1,424 shares during the quarter. United Advisor Group LLC’s holdings in Walgreens Boots Alliance were worth $95,000 at the end of the most recent quarter.

Other large investors have also recently bought and sold shares of the company. Iron Horse Wealth Management LLC lifted its position in Walgreens Boots Alliance by 162.5% during the 2nd quarter. Iron Horse Wealth Management LLC now owns 2,100 shares of the pharmacy operator’s stock worth $25,000 after acquiring an additional 1,300 shares in the last quarter. Blue Trust Inc. raised its stake in shares of Walgreens Boots Alliance by 87.0% in the 2nd quarter. Blue Trust Inc. now owns 2,324 shares of the pharmacy operator’s stock valued at $28,000 after purchasing an additional 1,081 shares in the last quarter. Continuum Advisory LLC lifted its position in shares of Walgreens Boots Alliance by 71.2% during the second quarter. Continuum Advisory LLC now owns 2,453 shares of the pharmacy operator’s stock worth $30,000 after purchasing an additional 1,020 shares during the last quarter. Sentry Investment Management LLC bought a new position in Walgreens Boots Alliance during the 3rd quarter worth approximately $30,000. Finally, Eastern Bank bought a new stake in Walgreens Boots Alliance during the third quarter valued at $33,000. Institutional investors and hedge funds own 58.59% of the company’s stock.

Walgreens Boots Alliance Stock Down 4.1 %

Shares of WBA opened at $9.23 on Thursday. The company has a 50-day simple moving average of $9.18 and a 200-day simple moving average of $12.30. The company has a debt-to-equity ratio of 0.67, a quick ratio of 0.37 and a current ratio of 0.68. Walgreens Boots Alliance, Inc. has a 52 week low of $8.22 and a 52 week high of $27.05. The firm has a market capitalization of $7.98 billion, a P/E ratio of -0.92, a P/E/G ratio of 1.22 and a beta of 0.69.

Walgreens Boots Alliance (NASDAQ:WBA) last issued its quarterly earnings data on Tuesday, October 15th. The pharmacy operator reported $0.39 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.03. Walgreens Boots Alliance had a negative net margin of 5.85% and a positive return on equity of 14.23%. The firm had revenue of $37.50 billion for the quarter, compared to analysts’ expectations of $35.75 billion. During the same period in the prior year, the firm earned $0.67 earnings per share. The company’s quarterly revenue was up 5.9% compared to the same quarter last year. On average, equities research analysts expect that Walgreens Boots Alliance, Inc. will post 1.53 earnings per share for the current year.

Walgreens Boots Alliance Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, December 12th. Investors of record on Monday, November 18th will be paid a dividend of $0.25 per share. The ex-dividend date is Monday, November 18th. This represents a $1.00 dividend on an annualized basis and a dividend yield of 10.83%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -9.99%.

Analyst Ratings Changes

A number of brokerages have issued reports on WBA. Jefferies Financial Group cut their target price on shares of Walgreens Boots Alliance from $19.00 to $9.00 and set a “hold” rating on the stock in a report on Wednesday, October 23rd. Bank of America lowered their price target on shares of Walgreens Boots Alliance from $11.00 to $7.50 and set an “underperform” rating for the company in a research report on Wednesday, September 4th. JPMorgan Chase & Co. decreased their price objective on Walgreens Boots Alliance from $20.00 to $15.00 and set an “overweight” rating for the company in a report on Friday, August 30th. Barclays increased their target price on shares of Walgreens Boots Alliance from $7.00 to $8.00 and gave the company an “underweight” rating in a research report on Wednesday, October 16th. Finally, TD Cowen dropped their price objective on Walgreens Boots Alliance from $16.00 to $14.00 and set a “buy” rating on the stock in a research note on Tuesday, October 22nd. Four analysts have rated the stock with a sell rating, nine have issued a hold rating and two have assigned a buy rating to the company. Based on data from MarketBeat.com, Walgreens Boots Alliance has a consensus rating of “Hold” and an average price target of $12.88.

Walgreens Boots Alliance Company Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.